Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H14ClN |
Molecular Weight | 195.689 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]1CNCCC2=C1C=C(Cl)C=C2
InChI
InChIKey=XTTZERNUQAFMOF-QMMMGPOBSA-N
InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1
Molecular Formula | C11H14ClN |
Molecular Weight | 195.689 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:41:10 UTC 2023
by
admin
on
Fri Dec 15 15:41:10 UTC 2023
|
Record UNII |
637E494O0Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
828021
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
||
|
WHO-ATC |
A08AA11
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
758920
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
||
|
LIVERTOX |
NBK548834
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
||
|
NCI_THESAURUS |
C47794
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
||
|
WHO-VATC |
QA08AA11
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
||
|
NDF-RT |
N0000185010
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
565816
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
||
|
DEA NO. |
1625
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
637E494O0Z
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
N0000185009
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | Serotonin 2c Receptor Agonists [MoA] | ||
|
CHEMBL360328
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
8128
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
C506658
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
N0000182137
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | Cytochrome P450 2D6 Inhibitors [MoA] | ||
|
65353
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
100000128165
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
LORCASERIN
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
8765
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
11658860
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
SUB34935
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
C76102
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
4374
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
1300701
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | RxNorm | ||
|
637E494O0Z
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
DTXSID3048659
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
616202-92-7
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
m6908
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | Merck Index | ||
|
2941
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY | |||
|
DB04871
Created by
admin on Fri Dec 15 15:41:10 UTC 2023 , Edited by admin on Fri Dec 15 15:41:10 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TARGET -> AGONIST |
EC50
|
||
|
OFF TARGET->WEAK AGONIST |
EC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TRANSPORTER -> NON-INHIBITOR |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
OFF-TARGET->AGONIST |
Ki
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
OFF TARGET->WEAK AGONIST |
EC50
|
||
|
TRANSPORTER -> NON-SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
OFF TARGET->WEAK AGONIST |
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
MINOR
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
M8 (1-carboxyl glucuronide) was excreted in urine greater than 10% of dose, but it was a minor metabolite in plasma.
URINE
|
||
|
METABOLITE -> PARENT |
MINOR
PLASMA
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
MINOR
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
MINOR
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Single Dose Administration |
|
||
Tmax | PHARMACOKINETIC |
|
Single Dose Administration |
|
||